R&D at SMS drives the company’s competitive edge, reflected in the introduction of pioneering products and processes with a superior price-value proposition. Strong R&D has been at the core of SMS growth since its inception. SMS started R&D activities with 4 doctorate scientists supported by 20 senior chemists in a 10000 Sq.ft area.

SMS recently expanded its R&D facilities by creating a state of art corporate research center with infrastructure and expertise to carry out all the activities from product conception to the development, scale up, stability studies culminating in preparation of the DMF.

SMS research team now comprises of about 100 scientists with expertise in process research, analytical research and scale up. A dedicated project management team handles costing, administration, purchase, and project monitoring. R&D capabilities of the company span across reaction technologies, organic compound categories, and novel catalytic systems. This center is capable of delivering top notch contract research modules to international clientele.

The R&D center is focused on lifestyle diseases and has made breakthroughs in anti-cancer, anti-migraine, anti-diabetic, anti-ulcer, important intermediates, and natural plant extracts. Development of non-infringing and cost effective alternative routes is the strength of SMS research center.


The R&D strategy at SMS is four pronged:

	Continuous sustained research on process optimization and cost reduction for commercialized products Decorative furnish  Building advice Development of scripts Accommodation of clauses
	One research group continously works on cost reduction for commercialized products. Best example being Ranitidine. Similarly success has been achieved in Sumatriptan Succinate and Gemicitabine.
	Development of innovative and cost effective process for existing products Products are strategically selected based on market conditions. Successful products are scaled up and commercialized and enable us to compete in the market with a cost effective process while maintaining margins
	NCE Research and development up to pre-clinical stage Ongoing NCE research work in Diuretic and Antidepressant therapeutic segment. SMS will sell promising NCE to multinationals for further clinical studies and development
	Providing contract research services to pharma majors Successful track record in executing numerous contract research assignments for top notch companies